Infection can be defined as attack of bacterial, viral or fungal
pathogens on the human (host) body and causing disturbance in the
normal functioning, on the other hand, study of resistance by human
body towards infections can be termed as immunology. The right
diagnosis and prevention of the infection is always a center for
studies on various infections. Infections and immunity together gives
innovative research approach towards interactions between bacterial,
viral and fungal pathogens and their hosts’ bodies. The current
study of immunology and infections rotate around handful of
infectious conditions namely AIDS, tuberculosis, malaria, hepatitis,
rotavirus, pneumonia, inflammatory bowel and some autoimmune
diseases.
The immunology market for infectious diseases comprises of diagnosis
and treatment of such infections based on the antibody and antigen
reaction. Innovations and developments in the immunological
technologies are very limited but focused on exploring the
applications in other infections. The major infections where
immunological products used are hepatitis, rotavirus infections, and
other viral and bacterial infections.
According to the journal published by BioMed Central, rotavirus
infection the leading cause of severe dehydrating diarrhea among
children worldwide. Every year rotavirus infection causes an
estimated 111 million diarrhea episodes leading to 2 million
hospitalization cases and 400,000 deaths of children under 5 years.
Out of all these 82% occur in children in the poorest countries of
Asia and Africa. As per Centers for Disease Control and Prevention
(CDC), chronic HBV affected almost 1.4 million of the US population
in 2011 and acting as major public health challenge. In past couple
of years outbreaks for different infections have deteriorated the
situation. All these reports direct towards the increasing need for
immunological diagnosis and treatment for infections across the
world. Therefore the market for this infection immunology may grow
with significant rate in near future. On the other hand high cost
involved and limited reach of this technology may hinder the growth
of the market.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2929
Infectious immunology market can be segmented according to different
categories such as regional geography and types of products used for
diagnosis and treatment of different infections. Geographically, this
market can be segmented in four regions namely North American,
Europe, Asia-Pacific and Rest of the World, of which North America
has the highest contribution in terms of value because of high
awareness and stringent measures towards diagnosis and immunization.
Followed by this is Europe, Asia-Pacific and Rest of the World
respectively contributing in decreasing order of value for the
market.
However the growth of the market may be significant in emerging
economies in Asia and Africa considering high incidence and
prevalence rate for infections. This market can also be segmented
according various categories of infections such as hepatitis viruses,
retroviruses and other infections. The market has different classes
of products used such as reagents, diagnostic kits, instruments and
others.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=2929<ype=S
Currently various established companies in diagnostic and healthcare
segment catering varied range of products such as reagents, test kits
and instruments in this market out of which companies such as F.
Hoffmann-La Roche Ltd., Abbott Laboratories, Shanghai Kehua
Bio-engineering Co., Ltd, Transasia Bio-Medicals Ltd, Span
Diagnostics Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories,
Inc. are leading contributors in reagents and test kits, on the other
hand Siemens Healthcare and PerkinElmer, Inc. are major companies in
Instruments segment.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment